Orion Genomics hopes to start pulling in revenues next year from its proprietary method of sequencing, mapping and cloning agricultural genes--technology that can be used to improve crop yield, develop pest resistance or help plants survive drought, flooding and cold.
While cloning stem cells is a technical breakthrough, there's already a method of deriving embryonic-like stem cells that doesn't require the use of embryos at all: induced pluripotent stem (IPS) cells, said Dr. George Daley, who is director of the Stem Cell Transplantation Program at Children's Hospital Boston and an international expert in stem cells.